Turkish Journal of Pharmaceutical Sciences

Turk J Pharm Sci: 20 (4)
Volume: 20  Issue: 4 - 2023
Show Abstracts | << Back
RESEARCH ARTICLE
1.Medication Reconciliation Service in Hospitalized Patients with Infectious Diseases during Coronavirus Disease 2019 pandemic: A Prospective Observational Study
Cüneyd Enver, Buket ERTURK SENGEL, MESUT SANCAR, VOLKAN KORTEN, Betul Okuyan
Pages 210 - 217

2.Validated Stability-indicating RP-HPLC Method for Daclatasvir in Tablets
Hemlata Manohar Nimje, Smita Pawar, Meenakshi Deodhar
Pages 218 - 225

3.LC-MS/MS method development and validation for the determination of favipiravir in pure and tablet dosage forms
Nandeesha Itigimath, Hadagali Ashoka, Basappa C Yallur, Manjunatha Devagondanahalli Hadagali
Pages 226 - 233

4.Development and validation of spectrofluorimetric method for the quantification of Capecitabine in bulk and tablets
Swathi Naraparaju, Ambati Mukti, Durga Panikumar Anumolu, soujanya chaganti
Pages 234 - 239

5.The role of chitosan-loaded solanine glycoalkaloid from Solanum scabrum Mill. leaf extract as anti-inflammatory and in vitro anticancer agents
Cletus Anes Ukwubile, EMMANUEL OISE IKPEFAN, Ademola Famurewa
Pages 240 - 252

6.Evaluation of Marketed Rosemary Essential Oils (Rosmarinus officinalis L.) in Terms of European Pharmacopoeia 10.0 Criteria
Timur Hakan Barak, Elif Bölükbaş, Hilal Bardakcı
Pages 253 - 260

7.Formulation, characterization and optimization of a topical gel containing tranexamic acid to prevent superficial bleeding: In vivo and in vitro evaluations
Sara Daneshmand, farideh shiehzadeh, Daryosh Mohebi, omid chavoshian
Pages 261 - 269

SHORT COMMUNICATION
8.Exploration of Structure Activity Relationship Using Integrated Structure and Ligand Based Approach: Hydroxamic Acid Based HDAC inhibitors and Cytotoxic Agents
Ekta Shirbhate, Jaiprakash Pandey, VIJAY KUMAR PATEL, RAVICHANDRAN VEERASAMY, Harish Rajak
Pages 270 - 284